MetLife reported a solid QQ3 2024 performance with revenue of USD 18.298 billion, up 15.3% year-over-year and 4.6% quarter-over-quarter. Gross profit of USD 5.447 billion produced a gross margin of approximately 29.8%, while operating income reached USD 1.994 billion, up about 150% year-over-year and 66% quarter-over-quarter. Net income totaled USD 1.342 billion, delivering EPS of USD 1.82 (diluted USD 1.81), representing roughly 174% year-over-year growth and about 42% sequential growth. Cash flow remained exceptionally strong, with net cash provided by operating activities of USD 4.169 billion and free cash flow of USD 4.169 billion, enabling shareholder-friendly capital allocation (dividends of USD 450 million and share repurchases of USD 774 million). The balance sheet shows substantial liquidity (cash and short-term investments of USD ~315.5 billion and total assets near USD 705 billion) with a manageable leverage profile (net debt negative, substantial liquidity versus liabilities). Valuation remains reasonable by many standards (P/E about 10.7x, P/BV about 1.87x, dividend yield ~0.78%), underpinning an attractive risk-adjusted yield given MetLife’s diversified earnings base. Management did not issue explicit forward guidance in the provided materials; investors should monitor investment income sensitivity to interest rates, ongoing capital deployment (dividends and buybacks), and the trajectory of key markets where MetLife operates.